Medtronic (MDT) Competitors $94.91 -0.68 (-0.71%) Closing price 09/19/2025 03:59 PM EasternExtended Trading$95.56 +0.65 (+0.68%) As of 09/19/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDT vs. DXCM, ISRG, ABT, JNJ, NVST, SYK, TMO, BSX, BDX, and IDXXShould you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include DexCom (DXCM), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), Johnson & Johnson (JNJ), Envista (NVST), Stryker (SYK), Thermo Fisher Scientific (TMO), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), and IDEXX Laboratories (IDXX). These companies are all part of the "medical" sector. Medtronic vs. Its Competitors DexCom Intuitive Surgical Abbott Laboratories Johnson & Johnson Envista Stryker Thermo Fisher Scientific Boston Scientific Becton, Dickinson and Company IDEXX Laboratories Medtronic (NYSE:MDT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment. Is MDT or DXCM more profitable? Medtronic has a net margin of 13.63% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Medtronic's return on equity.Company Net Margins Return on Equity Return on Assets Medtronic13.63% 14.61% 7.85% DexCom 13.29%30.41%10.08% Which has more risk and volatility, MDT or DXCM? Medtronic has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Do institutionals and insiders believe in MDT or DXCM? 82.1% of Medtronic shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.3% of Medtronic shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has higher valuation and earnings, MDT or DXCM? Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedtronic$34.20B3.56$4.66B$3.6326.15DexCom$4.30B6.15$576.20M$1.4446.84 Do analysts prefer MDT or DXCM? Medtronic presently has a consensus target price of $102.27, indicating a potential upside of 7.75%. DexCom has a consensus target price of $99.89, indicating a potential upside of 48.10%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Medtronic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medtronic 0 Sell rating(s) 8 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.65DexCom 0 Sell rating(s) 5 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.91 Does the media favor MDT or DXCM? In the previous week, Medtronic had 23 more articles in the media than DexCom. MarketBeat recorded 60 mentions for Medtronic and 37 mentions for DexCom. Medtronic's average media sentiment score of 1.38 beat DexCom's score of 0.89 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 51 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 20 Very Positive mention(s) 1 Positive mention(s) 12 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDexCom beats Medtronic on 11 of the 17 factors compared between the two stocks. Get Medtronic News Delivered to You Automatically Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDT vs. The Competition Export to ExcelMetricMedtronicMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$121.96B$10.61B$5.81B$21.64BDividend Yield2.97%1.88%5.61%3.50%P/E Ratio26.1521.6480.5029.94Price / Sales3.5640.59452.1859.71Price / Cash12.2724.5137.6624.98Price / Book2.533.4215.754.59Net Income$4.66B$210.63M$3.30B$1.00B7 Day Performance0.91%-0.02%5.35%0.81%1 Month Performance4.16%0.69%7.28%5.30%1 Year Performance6.23%-9.87%80.79%14.58% Medtronic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDTMedtronic4.9426 of 5 stars$94.91-0.7%$102.27+7.8%+6.2%$121.96B$34.20B26.1595,000News CoveragePositive NewsHigh Trading VolumeDXCMDexCom4.9772 of 5 stars$76.200.0%$99.89+31.1%-4.2%$29.86B$4.30B52.8810,300Trending NewsOptions VolumeISRGIntuitive Surgical4.9506 of 5 stars$435.49-3.2%$595.95+36.8%-9.8%$156.03B$8.35B60.7015,638News CoveragePositive NewsAnalyst RevisionABTAbbott Laboratories4.9381 of 5 stars$131.93-1.3%$144.47+9.5%+19.8%$229.49B$41.95B16.52114,000News CoveragePositive NewsDividend AnnouncementJNJJohnson & Johnson4.7042 of 5 stars$177.48-0.3%$176.29-0.7%+7.2%$427.14B$90.63B18.97138,100Trending NewsAnalyst ForecastNVSTEnvista3.7612 of 5 stars$21.07+0.3%$20.92-0.7%+10.1%$3.50B$2.51B65.7712,300Positive NewsSYKStryker4.9764 of 5 stars$379.62-1.0%$431.42+13.6%+3.2%$145.04B$23.82B50.2553,000News CoveragePositive NewsAnalyst UpgradeTMOThermo Fisher Scientific4.9676 of 5 stars$474.84-0.9%$592.24+24.7%-21.8%$179.01B$43.21B27.42125,000News CoveragePositive NewsBSXBoston Scientific4.869 of 5 stars$100.70-2.0%$118.04+17.2%+16.6%$149.12B$18.49B59.9053,000News CoveragePositive NewsAnalyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9595 of 5 stars$186.29-0.3%$211.44+13.5%-19.8%$53.36B$21.39B33.4874,000News CoveragePositive NewsIDXXIDEXX Laboratories4.1454 of 5 stars$648.04+1.1%$649.44+0.2%+29.5%$51.84B$4.04B53.9511,000Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies DXCM Competitors ISRG Competitors ABT Competitors JNJ Competitors NVST Competitors SYK Competitors TMO Competitors BSX Competitors BDX Competitors IDXX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MDT) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medtronic PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Medtronic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDT Stock Alerts